Literature DB >> 28960654

Survival and recurrence of resectable tongue cancer: Resection margin cutoff value by T classification.

Doh Young Lee1, Sung Hoon Kang1, Jae Hyung Kim1, Min-Su Kim1, Kyoung Ho Oh1, Jeong-Soo Woo1, Soon-Young Kwon1, Kwang-Yoon Jung1, Seung-Kuk Baek1.   

Abstract

BACKGROUND: The purpose of this study was to determine an appropriate cutoff value for the resection margin according to the initial T classification.
METHODS: The medical records of 151 patients treated by surgery for tongue cancer were retrospectively reviewed to identify the significant perioperative parameters and appropriate cutoff value associated with disease-specific survival (DSS) and recurrence-free survival (RFS).
RESULTS: The posterior resection margin was significantly correlated with survival and local recurrence (P = .020 and .016, respectively), whereas the deep resection margin was correlated with overall recurrence (P = .047). The cutoff values of the posterior and deep resection margins for survival and recurrence were different and larger in the advanced-stage T classification group (0.45 cm vs 0.95 cm and 0.25 cm vs 0.80 cm, respectively).
CONCLUSION: Posterior and deep resection margins are significant prognosticators in tongue cancer. A larger resection margin may be needed in advanced-stage T classification.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  recurrence; resection margin; survival; tongue cancer

Mesh:

Year:  2017        PMID: 28960654     DOI: 10.1002/hed.24944

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Ginsenoside Rd inhibits migration and invasion of tongue cancer cells through H19/miR-675-5p/CDH1 axis.

Authors:  Lu Chang; Dongxu Wang; Shaoning Kan; Ming Hao; Huimin Liu; Zhijing Yang; Qianyun Xia; Weiwei Liu
Journal:  J Appl Oral Sci       Date:  2022-09-02       Impact factor: 3.144

2.  The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.

Authors:  Giuseppe Troiano; Corrado Rubini; Lucrezia Togni; Vito Carlo Alberto Caponio; Khrystyna Zhurakivska; Andrea Santarelli; Nicola Cirillo; Lorenzo Lo Muzio; Marco Mascitti
Journal:  Cancer Med       Date:  2020-10-13       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.